Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Syed Naqvi

Concepts (45)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
4
2024
288
0.600
Why?
Skin Neoplasms
4
2024
505
0.400
Why?
Chemotherapy, Cancer, Regional Perfusion
3
2024
10
0.330
Why?
Extremities
3
2024
33
0.330
Why?
Melphalan
2
2024
181
0.250
Why?
Dactinomycin
1
2024
23
0.230
Why?
Small Cell Lung Carcinoma
1
2024
30
0.220
Why?
Sarcoma
1
2024
72
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1031
0.210
Why?
Antibodies, Monoclonal, Humanized
1
2024
236
0.200
Why?
Oncolytic Virotherapy
1
2021
21
0.190
Why?
Antibodies, Monoclonal
1
2024
481
0.170
Why?
Lung Neoplasms
1
2024
636
0.150
Why?
Aged, 80 and over
5
2024
3392
0.150
Why?
Immunoglobulin Variable Region
1
2017
17
0.140
Why?
Immunoglobulin Heavy Chains
1
2017
46
0.140
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
59
0.130
Why?
Genomics
1
2017
268
0.120
Why?
Herpesvirus 1, Human
2
2024
17
0.100
Why?
Adult
6
2024
14161
0.100
Why?
Aged
5
2024
10121
0.090
Why?
Retrospective Studies
4
2024
6607
0.090
Why?
Mutation
1
2017
1347
0.090
Why?
Middle Aged
5
2024
13028
0.090
Why?
Neoplasm Staging
2
2024
772
0.080
Why?
Male
6
2024
26761
0.070
Why?
Neoplasm Recurrence, Local
2
2021
649
0.070
Why?
Prognosis
2
2024
2099
0.060
Why?
Female
5
2024
28171
0.060
Why?
Humans
7
2024
52483
0.060
Why?
Neoplasm Metastasis
1
2024
243
0.050
Why?
Young Adult
2
2024
4329
0.050
Why?
Survival Rate
1
2024
945
0.050
Why?
Watchful Waiting
1
2021
28
0.050
Why?
Australia
1
2020
89
0.040
Why?
Sentinel Lymph Node Biopsy
1
2021
120
0.040
Why?
Lymph Node Excision
1
2021
133
0.040
Why?
Immunotherapy
1
2021
244
0.040
Why?
Follow-Up Studies
1
2024
2279
0.040
Why?
Chromosomes, Human, Pair 12
1
2017
14
0.030
Why?
Karyotype
1
2017
19
0.030
Why?
Trisomy
1
2017
35
0.030
Why?
In Situ Hybridization, Fluorescence
1
2017
263
0.030
Why?
Survival Analysis
1
2017
673
0.030
Why?
United States
1
2020
5192
0.020
Why?
Naqvi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description